Ritter Daniher Financial Advisory’s TriSalus Life Sciences TLSI Stock Holding History

Ritter Daniher Financial Advisory’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27K	Hold	500	–	–	﹤0.01%	549
2026 Q1	$2K	Hold	500	–	–	﹤0.01%	545
2025 Q4	$3.49K	Buy	+500	New	+$2.8K	﹤0.01%	531

Other funds holding TLSI

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Ritter Daniher Financial Advisory's TLSI Position: Q2 2026 in Review

Ritter Daniher Financial Advisory held its TriSalus Life Sciences (TLSI) position steady in Q2 2026 at 500 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Ritter Daniher Financial Advisory first reported a position in TLSI in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.49K in Q4 2025. 4 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Ritter Daniher Financial Advisory held 500 shares of TriSalus Life Sciences worth $2.27K as of Q2 2026.
Ritter Daniher Financial Advisory left its TriSalus Life Sciences share count unchanged in Q2 2026.
TriSalus Life Sciences made up ﹤0.01% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #549 holding.
Ritter Daniher Financial Advisory first reported a position in TriSalus Life Sciences in Q4 2025 and has held it in 3 quarters since.
Ritter Daniher Financial Advisory's TriSalus Life Sciences position peaked at $3.49K in Q4 2025.
4 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.